Topical Cannabinoids and Ocular Pain Relief

 

Topical Cannabinoids and Ocular Pain Relief

Endocannabinoid system (ECS) modulation has been observed to have a wide range of potential therapeutic benefits for multiple disorders, including ocular pain

Dr. Faktorovich | | 4 min read | Opinion

Headshot supplied by Dr. Ella Faktorovich

Though a number of different treatment options exist, safe and effective management of ocular pain remains a challenge. This year marks 60 years since the identification of the structure of two major cannabinoids – THC and CBD (

1
). This advance set in motion a series of discoveries leading to identification of the endocannabinoid system (ECS). This intricate signaling ystem of molecules, receptors, and enzymes is present in nearly all organs, including the eye, and ECS modulation has been observed to have a wide range of potential therapeutic benefits for multiple disorders, including ocular pain (
2
). Coupled with advances in drug delivery systems, ECS modulators have the potential to provide localized ophthalmic drug delivery that avoids systemic effects.

Both topical and systemic analgesics can effectively relieve acute ocular pain, but they have marked limitations in terms of their safety profile (
3
). For example, topical anesthetics and non-steroidal anti-inflammatory drugs (NSAIDs) may delay epithelial healing, whereas systemic gabapentinoids and opioids have been shown to lead to sedation and respiratory depression.

Treatment of chronic ocular pain can present an even greater challenge. This pain may accompany a chronic disease state, such as dry eye disease (DED) or diabetes, and though treatment of the underlying disease is essential, neuronal sensitization can still persist even when the disease is brought under control. Treatment options for chronic neuropathic pain include oral gabapentinoids, opioids, and tricyclic antidepressants. However, their efficacy is limited and the side effects may not be acceptable.

“ECS localization in the eye and on the neutrophils that may infiltrate the eye during inflammation”

There are three essential components of the ocular ECS: receptors, endogenous cannabinoids, and enzymes responsible for synthesis and degradation of receptors and cannabinoids. Acting to regulate pain transmission, cannabinoid 1 receptor (CB1R) has been identified throughout ocular tissues, whereas the cannabinoid 2 receptor (CB2R) is primarily localized to the surface of immune cells (

3
). Since ocular inflammation can result in both acute and chronic pain, the anti-inflammatory actions of CB2R modulation can have an indirect effect on improving ocular comfort. Reducing the release of noxious inflammatory mediators helps ameliorate acute pain, and prevention of neuronal sensitization by these mediators reduces the possibility of developing chronic neuropathic pain.

Since pain and inflammation often accompany DED, topical cannabinoids could also represent an important therapeutic approach to this condition. Because CB1R is present on the corneal epithelium, topical cannabinoids can easily access a desiccated epithelium – which can be a source of both acute and chronic ocular pain for DED patients – providing significant pain relief.

Interestingly, CB1R is also expressed in neurons innervating the lacrimal gland. Usually the expression is low, but this expression increases during DED-associated inflammation. McDowell et. al highlighted how CB1R activation reduces sensitization of lacrimal gland nerves, potentially reducing chronic neurotrophic pain (
4
). Tran et. al also demonstrated improvement in corneal fluorescence, and reduction of corneal and conjunctival inflammation after topical application of cannabinoids in experimentally induced dry eye models (
5
).

Other methods of ECS modulation are currently under investigation. One uses modulators that increase the binding affinity of cannabinoids to the receptors, allowing for a smaller dose of cannabinoid to achieve the desired effect; another method uses enzyme inhibitors that increase levels of endocannabinoids by inhibiting the actions of enzymes that degrade them. Treatment with enzyme inhibitors has been shown to reduce pain and inflammation in several preclinical models, including for chronic neuropathic pain (
3
).

There are challenges though; ECS modulators are hydrophobic, so the potential bottleneck of ocular penetration and bioavailability needs to be considered; here, nanotechnology-based drug delivery methods may prove useful.

The ubiquitous presence of the endocannabinoid system in ocular tissues, its role in ocular analgesia, and its demonstrated responsiveness to topical modulators represent a unique opportunity to continue developing a novel class of ECS ocular pain relief medications. These medications could either be used alone or in conjunction with other ocular analgesics to optimize ocular comfort, relieving both acute and chronic pain for patients.

Comments

Post a Comment

Popular posts from this blog

Cauda Equina Syndrome

Image
  Cauda Equina Syndrome (CES) is a serious medical condition requiring prompt attention. Definition Cauda Equina Syndrome occurs when the cauda equina nerves (lower spine) are compressed or damaged, disrupting communication between the brain and lower body. Causes 1. Herniated disc 2. Spinal stenosis 3. Trauma (fall, accident) 4. Infection (abscess, meningitis) 5. Tumor 6. Birth defects Symptoms 1. Severe low back pain 2. Pain, numbness, or tingling in legs 3. Weakness or paralysis in legs 4. Bladder and bowel dysfunction 5. Urinary retention or incontinence 6. Constipation 7. Sexual dysfunction Ocular Manifestations : Blurred vision can be an initial symptom of a schwannoma of the cauda equina, a rare nerve root problem that occurs when the nerves at the bottom of the spinal cord are compressed. Other ocular manifestations of conditions that can affect the cauda equina include: Neurosarcoidosis A multisystem disorder that can cause neurologic disease, including cranial n...
Read more

Epicanthic Folds and Hooded Eyelids, similarities and differences

Image
  Epicanthic folds are skin folds of the upper eyelid that cover the inner corner of the eye. There are four main types: - Epicanthus Supraciliaris: This type runs from the brow, curving downwards towards the Lacrimal sac. - Epicanthus Palpebralis: Beginning above the upper tarsus, it extends to the inferior orbital rim. - Epicanthus Tarsalis: Originating at the upper eyelid crease, it merges into the skin near the medial canthus. This type is most often found in East Asians. - Epicanthus Inversus: This type runs from the lower eyelid skin over the medial canthus and extends to the upper lid . These folds are more common in certain populations, including East Asians, Southeast Asians, Central Asians, North Asians, Polynesians, Micronesians, Indigenous peoples of the Americas, and some African people ¹. They can also be associated with various medical conditions, such as Down syndrome, Zellweger syndrome, and Noonan syndrome In terms of eye health, epicanthic folds may: - Decrea...
Read more

Nutrition and the Body

  Five signs that the body needs better  nutrition : B rittle nails, Eyelid twitching, Clicking of the joints, P remature graying of the hair and Easy bruising, translated as Fatigue, Skin issues, Digestive problems, Brain Fog and Weak Immune System Here are five signs that your body may need more nutrition: 1. Fatigue and Low Energy - Feeling tired or sluggish throughout the day - Difficulty concentrating or staying focused - Needing excessive caffeine or sugar for energy 1. Skin Issues - Dry, dull, or acne-prone skin - Hair loss or brittle hair - Nail problems (brittle, thin, or slow-growing) 1. Digestive Problems - Bloating, gas, or abdominal pain - Constipation or diarrhea - Difficulty absorbing nutrients 1. Mood Swings and Brain Fog - Irritability, anxiety, or depression - Difficulty remembering or learning new information - Mood swings or emotional instability 1. Weakened Immune System - Frequent illnesse...
Read more